Menu Back toSession-7-OPDP-Research-Panel

Advertising and Promotion Regulatory Affairs Conference


Session 7: OPDP Research Panel

    Session Chair(s)
      Glenn N. Byrd, MBA, RAC

      Glenn N. Byrd, MBA, RAC

      • Senior Director, Specialty Care Promotional Regulatory Affairs
      • AstraZeneca, United States
    Individual FDA/OPDP researchers will present topics of their own research and will highlight plans for upcoming research. Gain a better understanding of the FDA/OPDP Research program and how it may contribute to knowledge, guidance, and policy development.
    Learning Objective : At the conclusion of this session, participants should be able to:
    • Describe the holistic research agenda of FDA/OPDP
    • Identify individual topic areas and how they fit together
    • Review results of recent research
    Speaker(s)
      Kathryn J. Aikin, PhD

      Research Update and Preview from OPDP

      Kathryn J. Aikin, PhD

      • Senior Social Science Analyst, Research Team Lead, OPDP, CDER
      • FDA, United States
      Amie C O'Donoghue, PhD

      Who’s Watching and How is it Structured: The Major Statement in DTC Television Ads

      Amie C O'Donoghue, PhD

      • Social Science Analyst, OPDP, CDER
      • FDA, United States
      Helen W. Sullivan, PhD, MPH

      A Content Analysis of the Major Statement in DTC Television Ads

      Helen W. Sullivan, PhD, MPH

      • Social Science Analyst, OPDP, CDER
      • FDA, United States

Contact us

Customer Service

1.888.257.6457


Call for Posters Extended: January 16

Guidelines | Submit


Complimantary Webinar

Navigating the Still Murky Waters of Manufacturer Communications: Promotion, Commercial Speech, and Scientific Exchange
Jan. 17 | 11:00AM-12:00PM ET


Preconference Short Course Options

Ad Promo Primer